Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors.
Rullo M, La Spada G, Miniero DV, Gottinger A, Catto M, Delre P, Mastromarino M, Latronico T, Marchese S, Mangiatordi GF, Binda C, Linusson A, Liuzzi GM, Pisani L. Rullo M, et al. Among authors: mastromarino m. Eur J Med Chem. 2023 Jul 5;255:115352. doi: 10.1016/j.ejmech.2023.115352. Epub 2023 Apr 8. Eur J Med Chem. 2023. PMID: 37178666
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders.
Mastromarino M, Favia M, Schepetkin IA, Kirpotina LN, Trojan E, Niso M, Carrieri A, Leśkiewicz M, Regulska M, Darida M, Rossignolo F, Fontana S, Quinn MT, Basta-Kaim A, Leopoldo M, Lacivita E. Mastromarino M, et al. J Med Chem. 2022 Mar 24;65(6):5004-5028. doi: 10.1021/acs.jmedchem.1c02203. Epub 2022 Mar 8. J Med Chem. 2022. PMID: 35257581 Free PMC article.
Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder.
Lacivita E, Niso M, Mastromarino M, Garcia Silva A, Resch C, Zeug A, Loza MI, Castro M, Ponimaskin E, Leopoldo M. Lacivita E, et al. Among authors: mastromarino m. ACS Chem Neurosci. 2021 Apr 21;12(8):1313-1327. doi: 10.1021/acschemneuro.0c00647. Epub 2021 Apr 1. ACS Chem Neurosci. 2021. PMID: 33792287 Free article.
The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1-42)-Induced Neuroinflammation in Mouse Models of Alzheimer's Disease.
Trojan E, Tylek K, Schröder N, Kahl I, Brandenburg LO, Mastromarino M, Leopoldo M, Basta-Kaim A, Lacivita E. Trojan E, et al. Among authors: mastromarino m. Mol Neurobiol. 2021 Dec;58(12):6203-6221. doi: 10.1007/s12035-021-02543-2. Epub 2021 Sep 1. Mol Neurobiol. 2021. PMID: 34468933 Free PMC article.
TNM Staging System in Thymoma: A Critical Appraisal?
Ambrogi MC, Aprile V, Lenzini A, Bacchin D, Mastromarino MG, Korasidis S, Lucchi M. Ambrogi MC, et al. Among authors: mastromarino mg. J Clin Med. 2024 Jan 21;13(2):610. doi: 10.3390/jcm13020610. J Clin Med. 2024. PMID: 38276116 Free PMC article. Review.
New Immunohistochemical Markers for Pleural Mesothelioma Subtyping.
Di Stefano I, Alì G, Poma AM, Bruno R, Proietti A, Niccoli C, Zirafa CC, Melfi F, Mastromarino MG, Lucchi M, Fontanini G. Di Stefano I, et al. Among authors: mastromarino mg. Diagnostics (Basel). 2023 Sep 14;13(18):2945. doi: 10.3390/diagnostics13182945. Diagnostics (Basel). 2023. PMID: 37761312 Free PMC article.
32 results